Long-Term Assets: The sum of all assets classified as non-current.
ADMA Biologics Inc (ADMA) had Long-Term Assets of $72.17M for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$258.21M |
|
$-28.24M |
|
$169.27M |
|
$88.94M |
|
$236.58M |
|
$21.63M |
|
$-49.87M |
|
$-28.24M |
|
$-28.24M |
|
$-28.24M |
|
$-28.24M |
|
$-28.24M |
|
$-28.24M |
|
$21.63M |
|
$32.41M |
|
223.98M |
|
223.98M |
|
$-0.13 |
|
$-0.13 |
|
| Balance Sheet Financials | |
$257.01M |
|
$53.84M |
|
|
Long-Term Assets |
$72.17M |
$329.18M |
|
$49.81M |
|
$140.37M |
|
$144.17M |
|
$193.98M |
|
$135.21M |
|
$131.18M |
|
$135.21M |
|
226.06M |
|
| Cash Flow Statement Financials | |
$8.80M |
|
$-4.98M |
|
$-38.99M |
|
$86.52M |
|
$51.35M |
|
$-35.17M |
|
$6.19M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.16 |
|
-- |
|
-- |
|
0.51 |
|
1.05 |
|
34.44% |
|
8.38% |
|
8.38% |
|
12.55% |
|
-10.94% |
|
-10.94% |
|
$4.03M |
|
-- |
|
-- |
|
-- |
|
0.78 |
|
0.98 |
|
9.42 |
|
38.76 |
|
-20.89% |
|
-21.53% |
|
-8.58% |
|
-10.25% |
|
$0.60 |
|
$0.02 |
|
$0.04 |
|